195 related articles for article (PubMed ID: 17567569)
1. Confocal Raman microscopy can quantify advanced glycation end product (AGE) modifications in Bruch's membrane leading to accurate, nondestructive prediction of ocular aging.
Glenn JV; Beattie JR; Barrett L; Frizzell N; Thorpe SR; Boulton ME; McGarvey JJ; Stitt AW
FASEB J; 2007 Nov; 21(13):3542-52. PubMed ID: 17567569
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end product (AGE) accumulation on Bruch's membrane: links to age-related RPE dysfunction.
Glenn JV; Mahaffy H; Wu K; Smith G; Nagai R; Simpson DA; Boulton ME; Stitt AW
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):441-51. PubMed ID: 18676633
[TBL] [Abstract][Full Text] [Related]
3. Sclera as a surrogate marker for determining AGE-modifications in Bruch's membrane using a Raman spectroscopy-based index of aging.
Beattie JR; Pawlak AM; McGarvey JJ; Stitt AW
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1593-8. PubMed ID: 21398274
[TBL] [Abstract][Full Text] [Related]
4. Increase in the advanced glycation end product pentosidine in Bruch's membrane with age.
Handa JT; Verzijl N; Matsunaga H; Aotaki-Keen A; Lutty GA; te Koppele JM; Miyata T; Hjelmeland LM
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):775-9. PubMed ID: 10067983
[TBL] [Abstract][Full Text] [Related]
5. Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes.
Spraul CW; Lang GE; Grossniklaus HE; Lang GK
Surv Ophthalmol; 1999 Oct; 44 Suppl 1():S10-32. PubMed ID: 10548114
[TBL] [Abstract][Full Text] [Related]
6. Multiplex analysis of age-related protein and lipid modifications in human Bruch's membrane.
Beattie JR; Pawlak AM; Boulton ME; Zhang J; Monnier VM; McGarvey JJ; Stitt AW
FASEB J; 2010 Dec; 24(12):4816-24. PubMed ID: 20686107
[TBL] [Abstract][Full Text] [Related]
7. The expression of advanced glycation endproduct receptors in rpe cells associated with basal deposits in human maculas.
Yamada Y; Ishibashi K; Ishibashi K; Bhutto IA; Tian J; Lutty GA; Handa JT
Exp Eye Res; 2006 May; 82(5):840-8. PubMed ID: 16364296
[TBL] [Abstract][Full Text] [Related]
8. Spectral profiling of autofluorescence associated with lipofuscin, Bruch's Membrane, and sub-RPE deposits in normal and AMD eyes.
Marmorstein AD; Marmorstein LY; Sakaguchi H; Hollyfield JG
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2435-41. PubMed ID: 12091448
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation endproduct changes to Bruch's membrane promotes lipoprotein retention by lipoprotein lipase.
Cano M; Fijalkowski N; Kondo N; Dike S; Handa J
Am J Pathol; 2011 Aug; 179(2):850-9. PubMed ID: 21801873
[TBL] [Abstract][Full Text] [Related]
10. Iron accumulation in Bruch's membrane and melanosomes of donor eyes with age-related macular degeneration.
Biesemeier A; Yoeruek E; Eibl O; Schraermeyer U
Exp Eye Res; 2015 Aug; 137():39-49. PubMed ID: 26026877
[TBL] [Abstract][Full Text] [Related]
11. Peripapillary chorioretinal atrophy: Bruch's membrane changes and photoreceptor loss.
Curcio CA; Saunders PL; Younger PW; Malek G
Ophthalmology; 2000 Feb; 107(2):334-43. PubMed ID: 10690836
[TBL] [Abstract][Full Text] [Related]
12. Proteomic profiling of human retinal pigment epithelium exposed to an advanced glycation-modified substrate.
Glenn JV; Mahaffy H; Dasari S; Oliver M; Chen M; Boulton ME; Xu H; Curry WJ; Stitt AW
Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):349-59. PubMed ID: 22081232
[TBL] [Abstract][Full Text] [Related]
13. TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration.
Kamei M; Hollyfield JG
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2367-75. PubMed ID: 10476804
[TBL] [Abstract][Full Text] [Related]
14. Bruch's membrane aging decreases phagocytosis of outer segments by retinal pigment epithelium.
Sun K; Cai H; Tezel TH; Paik D; Gaillard ER; Del Priore LV
Mol Vis; 2007 Dec; 13():2310-9. PubMed ID: 18199972
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural aging of the RPE-Bruch's membrane-choriocapillaris complex in the D-galactose-treated mouse.
Ida H; Ishibashi K; Reiser K; Hjelmeland LM; Handa JT
Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2348-54. PubMed ID: 15223816
[TBL] [Abstract][Full Text] [Related]
16. Development of a polyclonal antibody with broad epitope specificity for advanced glycation endproducts and localization of these epitopes in Bruch's membrane of the aging eye.
Farboud B; Aotaki-Keen A; Miyata T; Hjelmeland LM; Handa JT
Mol Vis; 1999 Jul; 5():11. PubMed ID: 10407062
[TBL] [Abstract][Full Text] [Related]
17. Reduction of endogenous angiogenesis inhibitors in Bruch's membrane of the submacular region in eyes with age-related macular degeneration.
Bhutto IA; Uno K; Merges C; Zhang L; McLeod DS; Lutty GA
Arch Ophthalmol; 2008 May; 126(5):670-8. PubMed ID: 18474778
[TBL] [Abstract][Full Text] [Related]
18. The dynamic nature of Bruch's membrane.
Booij JC; Baas DC; Beisekeeva J; Gorgels TG; Bergen AA
Prog Retin Eye Res; 2010 Jan; 29(1):1-18. PubMed ID: 19747980
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of Drusen and Bruch's membrane in postmortem eyes with age-related macular degeneration.
Spraul CW; Grossniklaus HE
Arch Ophthalmol; 1997 Feb; 115(2):267-73. PubMed ID: 9046265
[TBL] [Abstract][Full Text] [Related]
20. [Drusen in Bruch's membrane. Their significance for the pathogenesis and therapy of age-associated macular degeneration].
Pauleikhoff D
Ophthalmologe; 1992 Oct; 89(5):363-86. PubMed ID: 1304217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
